Literature DB >> 22505209

Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice.

Yu-Chen Hsu1, Hsiang-Po Huang, I-Shing Yu, Kang-Yi Su, Shu-Rung Lin, Wei-Chou Lin, Hua-Lin Wu, Guey-Yueh Shi, Mi-Hua Tao, Cheng-Heng Kao, Yao-Ming Wu, Patricia E Martin, Shih-Yao Lin, Pan-Chyr Yang, Shu-Wha Lin.   

Abstract

UNLABELLED: The liver architecture plays an important role in maintaining hemodynamic balance, but the mechanisms that underlie this role are not fully understood. Hepsin, a type II transmembrane serine protease, is predominantly expressed in the liver, but has no known physiological functions. Here, we report that hemodynamic balance in the liver is regulated through hepsin. Deletion of hepsin (hepsin(-/-) ) in mice resulted in enlarged hepatocytes and narrowed liver sinusoids. Using fluorescent microbeads and antihepsin treatment, we demonstrated that metastatic cancer cells preferentially colonized the hepsin(-/-) mouse liver as a result of the retention of tumor cells because of narrower sinusoids. The enlarged hepatocytes expressed increased levels of connexin, which resulted from defective prohepatocyte growth factor (pro-HGF) processing and decreased c-Met phosphorylation in the livers of hepsin(-/-) mice. Treatment of hepsin(-/-) mice with recombinant HGF rescued these phenotypes, and treatment of wild-type mice with an HGF antagonist recapitulated the phenotypes observed in hepsin(-/-) mice.
CONCLUSION: Our findings show that the maintenance of hepatic structural homeostasis occurs through HGF/c-Met/connexin signaling by hepsin, and hepsin-mediated changes in liver architecture significantly enhance tumor metastasis to the liver.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505209     DOI: 10.1002/hep.25773

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  The role of type II transmembrane serine protease-mediated signaling in cancer.

Authors:  Lauren M Tanabe; Karin List
Journal:  FEBS J       Date:  2016-12-24       Impact factor: 5.542

2.  The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice.

Authors:  Caroline A Enns; Shall Jue; An-Sheng Zhang
Journal:  Blood       Date:  2020-08-20       Impact factor: 22.113

3.  Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion.

Authors:  T A Tervonen; D Belitškin; S M Pant; J I Englund; E Marques; H Ala-Hongisto; L Nevalaita; H Sihto; P Heikkilä; M Leidenius; K Hewitson; M Ramachandra; A Moilanen; H Joensuu; P E Kovanen; A Poso; J Klefström
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

Review 4.  Type II transmembrane serine proteases as potential targets for cancer therapy.

Authors:  Andrew S Murray; Fausto A Varela; Karin List
Journal:  Biol Chem       Date:  2016-09-01       Impact factor: 3.915

Review 5.  The role of the cell-cell interactions in cancer progression.

Authors:  Katarzyna Kamińska; Cezary Szczylik; Zofia F Bielecka; Ewa Bartnik; Camillo Porta; Fei Lian; Anna M Czarnecka
Journal:  J Cell Mol Med       Date:  2015-01-19       Impact factor: 5.310

6.  Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis.

Authors:  Xi Tang; Sumit S Mahajan; Liem T Nguyen; François Béliveau; Richard Leduc; Julian A Simon; Valeri Vasioukhin
Journal:  Oncotarget       Date:  2014-03-15

7.  The serine protease hepsin mediates urinary secretion and polymerisation of Zona Pellucida domain protein uromodulin.

Authors:  Martina Brunati; Simone Perucca; Ling Han; Angela Cattaneo; Francesco Consolato; Annapaola Andolfo; Céline Schaeffer; Eric Olinger; Jianhao Peng; Sara Santambrogio; Romain Perrier; Shuo Li; Marcel Bokhove; Angela Bachi; Edith Hummler; Olivier Devuyst; Qingyu Wu; Luca Jovine; Luca Rampoldi
Journal:  Elife       Date:  2015-12-17       Impact factor: 8.140

8.  Defective Tmprss3-Associated Hair Cell Degeneration in Inner Ear Organoids.

Authors:  Pei-Ciao Tang; Alpha L Alex; Jing Nie; Jiyoon Lee; Adam A Roth; Kevin T Booth; Karl R Koehler; Eri Hashino; Rick F Nelson
Journal:  Stem Cell Reports       Date:  2019-06-13       Impact factor: 7.765

9.  Hepsin regulates TGFβ signaling via fibronectin proteolysis.

Authors:  Topi A Tervonen; Juha Klefström; Denis Belitškin; Shishir M Pant; Pauliina Munne; Ilida Suleymanova; Kati Belitškina; Hanna-Ala Hongisto; Johanna Englund; Tiina Raatikainen; Olga Klezovitch; Valeri Vasioukhin; Shuo Li; Qingyu Wu; Outi Monni; Satu Kuure; Pirjo Laakkonen; Jeroen Pouwels
Journal:  EMBO Rep       Date:  2021-09-13       Impact factor: 8.807

10.  HEV-ORF3 Encoding Phosphoprotein Interacts With Hepsin.

Authors:  Chunyan Wang; Liang Guo; Dayi Yu; Xiuguo Hua; Zhibiao Yang; Congli Yuan; Li Cui
Journal:  Hepat Mon       Date:  2014-01-18       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.